Roche
NEWS
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 17, 2020.
Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease.
“We are excited to partner with Roche’s strong research and development team,” said Michael Gilman, Arrakis’ chief executive officer.
A summary of daily biopharma industry news. Please check out stories that are trending on March 25, 2020.
“The industry is increasing capacities, but at the same time infection rates are even increasing faster,” said Roche CEO Severin Schwan. “At the moment, capacities are limited. That is why we have to prioritize testing to higher risk patients.”
A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.
The company has initiated a late-stage trial assessing its rheumatoid arthritis drug Actemra in patients who have severe COVID-19 caused pneumonia.
A summary of daily Biopharma industry news. Please check out stories that are trending on March 19, 2020.
Hospitals and laboratories will be able to run the test on Roche’s fully automated cobas 6800 and cobas 8800 Systems, which are already in wide use in the U.S. and internationally.
JOBS
IN THE PRESS